We are builders, enablers, success-makers. We are Accelitech, and we’re here to make it easy for you. We deliver the most advanced technology. Fast.
With over 10 years of experience, having developed 13 cancer treatment centers, and deploying over $100 million in solutions, we can comfortably say that we’ve been in your shoes and understand what it takes to succeed. Our real-world experience gives us a vast network of solution providers from which to draw best practices and operational efficiencies. Front-end feasibility work. Back-end consulting services. Custom-designed financing solutions. You can turn over all the details to us, and even finance the whole project with our industry-first volumetric leasing model. We have you covered!
We can take an active role in the short- and long-term planning, if needed – so you and your physicians can do what you do best: provide the highest quality care possible.
Accelitech has real-world experience and the know-how to deliver on time, on budget, and with an obsessive commitment to doing the job right. We can service any portion of the process – consulting solutions, device procurement, financing, even turnkey solutions, you name it. A true engineered solution that gives you confidence for the future and a few more hours in your day.
We can deliver a complete suite of Varian devices, giving you the most advanced lifesaving technology on the market. And we can stick around after build-out and installation to provide consulting or any support your team may need.
Our unprecedented flexible financing options enable you to access the most advanced technology in the way that works for your institution. Volumetric, off-balance sheet financing, and non-recourse terms all add up to peace of mind and a personalized solution that will surely add value within your budget.
We engineer a solution that’s right for you. On an a la carte basis, choose any of our services, from planning, to build-out, to financing, to consulting, or contract with us to handle everything, from beginning to end.
Kerwin J. Brandt, President and Chief Executive Officer, is responsible for leading the Accelitech team, ensuring that key milestones are achieved, maintaining strategic partnerships within the healthcare industry, and securing funding necessary for targeted growth. Kerwin also manages the joint venture and technology financing arrangements. Prior to founding Accelitech, Kerwin was the Senior Vice President, Technology Ventures and Chief Financial Officer at NeuroSource. There, he served as Head of Operations over the Technology Ventures unit, consisting of a national network of hospital-based stereotactic radiosurgery joint ventures with physicians and hospitals. As CFO, Kerwin managed the financial operations within the company and completed capital raises (including asset-based senior loans, mezzanine financing, subordinated debt, equipment leases, REIT sale leaseback and equity transactions). During his tenure, Kerwin led the financial team in the acquisition and transfer of an 85-bed specialty hospital. He also established and served as a director of the board for an offshore captive insurance company. Prior to joining NeuroSource, Kerwin served as Vice President, Finance and Administration for CallConnect Communications. While at CallConnect, Kerwin directed the concurrent completion of an acquisition of a telecommunication business servicing the healthcare industry and a related debt and equity capital raise. Earlier in his career, Kerwin spent four years with BDO Seidman as an Audit Manager and Manager of Centralized Accounting for Service Master Home Health Care. Kerwin holds an MBA from Illinois Benedictine College in Lisle, Illinois, and a BA in accounting with a minor in economics from the University of Northern Iowa. He passed the CPA exam in 1990.
David G. Sheffert, Chief Legal Officer, General Counsel, is responsible for the design, development, structuring and implementation of special purpose entities, joint ventures and partnerships that achieve desired business goals. Over the last ten years at Accelitech, he has served as the legal architect for numerous hospital based technology joint ventures that have included private placement capital raises, structured debt financings, facility construction, technology acquisition, management services arrangements, and acquisitions. In addition, he has structured, capitalized and counseled several business start-ups including Accelitech, PetCure Oncology LLC and Dublin CyberKnife Financing Ltd., a special purpose leasing company operating in Ireland. His efforts include maintaining a current understanding of the federal and state laws that pertain to hospital and physician joint ventures, leasing structures, syndication strategies, corporate and securities laws and legal issues related to technology and business starts. Prior to founding Accelitech, Dave served as Vice President Legal, General Counsel for NeuroSource, a venture funded company focused in the neurosciences. During his tenure, he was responsible for the legal oversight of practice acquisitions, hospital joint ventures, technology joint ventures, risk management, debt structures, and investor relations. Specific projects included the acquisition, financing and operation of an 85 bed neurosurgical specialty hospital, developing a national network of hospital-based stereotactic radiosurgery joint ventures, and forming and capitalizing an offshore captive insurance company. Prior to joining NeuroSource, Dave was a practicing attorney at Ungaretti & Harris for five years with a focus on health care regulatory and transactional projects. Earlier in his career, and while attending law school, Dave was a Senior Underwriter – National Accounts for BlueCross BlueShield of Illinois, and before that an group health underwriter with Lincoln National Life. Dave received a JD from Loyola University of Chicago in 1993 and a BS in Business Economics and Public Policy along with Certificates in Environmental Studies and European Studies from Indiana University in 1985. Dave has been an active member of the Illinois Bar since 1983.
James A. Te Winkle, Founding Partner and Chief Strategy Officer , is responsible for developing and implementing Accelitech’s business strategy and identifying market transitions to support the company as it moves into new, adjacent markets in both the human and veterinary cancer care segments. Prior to founding Accelitech and PetCure Oncology, Jim’s business experience included development positions at Neurosource, American Hospital Association, and Health Management Resources. Jim’s clinical experience includes senior management roles in cardiovascular disease management, cardiovascular research and exercise physiology, behavior management, and nursing. Jim holds a MBA, MS in Exercise Science and Cardiovascular Research, and a BS in Nursing. Career highlights include:
– 10+ years business start-up experience as founding partner in 2 nationally based companies
– Thought leader for and board member on human focused national radiosurgery organization and member of the Scientific Advisory Board for Veterinary Radiosurgery
– Developed 25+ national/international human and veterinary radiosurgery programs including design, operations and marketing
– 30+ years of healthcare experience in clinical, business development and operations
Samantha Skubish is the Vice President, Consulting Services at Accelitech. Samantha and her team work with hospital and health care provider clients to identify new market opportunities, empower them to enhance their short and long-term market position, refine operations and maintain the highest quality of care. Samantha has extensive experience in the areas of clinical operations, strategic planning, capital solutions, marketing, process improvement, data driven market growth, acquisition strategies and executive level project management. Samantha oversees and supports all consulting projects ensuring each client is provided the tools and guidance to exceed their goals and expectations. Prior to Accelitech, Samantha held leadership positions at various renowned hospitals and health systems across the country including Memorial Sloan-Kettering Cancer Center in New York, NY and Mount Sinai Medical Center in Miami Beach, FL. Samantha is a fellowship trained hospital administrator with a clinical background in radiology and radiation oncology. She holds a Master’s degree in Health Services Management and Policy from The New School in New York, NY and a Bachelor’s degree in Radiologic Science from Southern Illinois University in Carbondale, IL. She is a member of the American College of Healthcare Executives and the American Society for Radiologic Technologists.